IV. 10 Self-directed maintenance: a lifestyle system against relapse

The course ends, but your recovery does not. This final chapter helps you turn the habits built over the ninety days into a durable lifestyle system – one that feeds the engrafted flora and keeps relapse at bay. Antibiotic awareness, a diverse diet, sleep, exercise: the wheel comes into your own hands.

The lifestyle that stays

The best protection against relapse is not a tablet, but the environment you create for your gut day after day. The engrafted, diverse flora stays strong if you feed it what it likes: varied, plant-based fibres. Aim for many kinds of plant source to reach your plate each week – vegetables, fruits, pulses, whole grains, seeds. Diversity is more important here than quantity: the more kinds of fibre, the more kinds of useful bacteria find food.

Alongside these are the now-familiar basics: enough fluid, regular, gentle exercise, and respect for rest. It is worth keeping a few other small habits too, that proved their worth over the 90 days: regular fermented food^[G] (sauerkraut, kefir), which brings live microorganisms and fermentation metabolites into the system – the more often it features in the diet, the better [161]; the gentle maintenance of the eating window, that is, the earlier, lighter dinner and the daytime-weighted eating; and social contact – a regular conversation, a close relationship – which not only relieves stress but is also an independent health-protective factor. These are not new tasks – over the ninety days they have already become part of you. Maintenance is just not letting them go once the acute situation has passed. A habit truly protects only if it remains part of everyday life.

Antibiotic awareness: the most important new reflex

Behind recurrent C. difficile infection there most often lies the emptying-out of the flora, and the most common cause of this is the antibiotic. This does not mean that the antibiotic is bad – in many situations it saves lives. It means that it must be handled consciously. In future, if any doctor were to prescribe an antibiotic, always mention that you have had recurrent C. difficile infection – this is important information for them. Ask whether the antibiotic is genuinely necessary, whether there is a narrower-spectrum or shorter alternative, and take it only when, and how, it is prescribed [023].

This awareness is the most valuable thing you carry with you from the programme. A single well-timed question in the doctor's office can prevent another relapse.

Your own system

There is an important thought worth closing together with the 90 days themselves. The high-dose course at the time opened a protected window: the symptoms eased, while the fresh flora settled and gradually took hold – and meanwhile colonisation resistance was restored, which inhibits the germination and overgrowth of C. difficile (Britton & Young 2014 [002]). The protected window is an image for this phase, not a physiological state. In this window you built in those habits that you now carry with you – and it is precisely these habits that are your real, long-term insurance against relapse. When the capsule support ran out, you were not left defenceless: the protection was taken over by your diverse diet, your rhythm, your exercise and your relationships. The protected window has therefore closed, but the foundation laid within it has remained – and this is what you build on from here.

Durable maintenance is not a rigid list of rules, but a flexible system that you tailor to yourself. Keep what proved its worth over the ninety days: if the diary helped, keep it up less often; if the weekly plant diversity^[G] went well, make a habit of it; if you know what the red flag is, do not forget it. From time to time, especially with a major life change or in a stressful period, it is worth consciously returning to the basics. And keep in touch with your doctor: the check-ups, the follow-up, are not a sign of illness, but of responsible care. With this system, your recovery is not an event, but a state that you yourself maintain.

🍽️ Eating during these days

The theme of this closing chapter is self-directed maintenance – and one of its main pillars is precisely eating: the diverse, plant-based diet that keeps the engrafted flora strong and resilient once the capsule support has run out. The concrete eating task for the three days follows directly from the daily tasks: build your weekly diversity plan (20–30 plant sources, target 30+ per week), keep the fluid, sleep and exercise routine, and each day include the plant of the day in at least one meal.

For these days (88–90), the Plant Calendar (Appendix F) brings alfalfa sprouts (88), nutritional yeast (89), and for day 90 the rainbow plate – the celebration of 30+ plants a week. Sprouts provide enzymes and fresh plant variety, nutritional yeast provides beta-glucan^[G] and B vitamins, and the rainbow plate is itself the symbol of the goal: as many colours and plant species as possible on one plate. As the close of the second half of the programme (roughly days 61–90), the goal is precisely this: the durable maintenance of full plant diversity and fermentable fibre sources, because a high and varied fibre intake is the main driver of microbiome diversity and butyrate^[G] production – and the diverse, stable flora provides the durable, resilient basis of colonisation resistance^[G]. This is the habit you keep after the 90 days too: not a diet, but a self-tailored, sustainable system that keeps relapse at bay over the long term.

Why does this matter?

Maintenance is the most durable benefit of the programme: not a course, but a lifestyle that strengthens the engrafted flora and keeps relapse at bay. The two most important things you carry with you are the diverse, fibre-rich diet and antibiotic awareness – these two are the most faithful protectors of your gut. The ninety days taught you how to live so that C. difficile cannot find its way back. From here the wheel is yours – and now you know how to keep it steady.

References

[002] Britton R, Young V. Role of the intestinal microbiota in resistance to colonization by Clostridium. difficile. Gastroenterology. 2014. Link

Intestinal microbiota and C. difficile colonization resistance — fundamental mechanisms — The native microbiota inhibits germination and growth of C. difficile spores. Antibiotics impair this defense. Key mechanisms: bile acid metabolism, nutrient competition. FMT restores colonization resistance.

[007] Chilton C, Pickering D, Freeman J. Microbiologic factors affecting Clostridium. difficile recurrence. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018. Link

Microbiological causes of C. difficile recurrence — spore persistence and dysbiosis — Low bacterial diversity correlates with clinical rCDI. Spore persistence + germination is the key to recurrence. FMT and microbiota therapies are increasingly investigated. Targeted antibiotics (fidaxomicin) + microbiota restoration form the combined approach.

[023] McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC et al. Clinical Practice Guidelines for Clostridium. difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases. 2018. Link

Comprehensive IDSA/SHEA clinical practice guideline on the diagnosis, treatment and prevention of C. difficile infection in adults and children. It defines severity categories (non-severe, severe, fulminant) and characterises fulminant disease by hypotension or shock, ileus or toxic megacolon — findings that require inpatient care, intravenous therapy and surgical consultation. For multiply recurrent infection in which antibiotic therapy has repeatedly failed, faecal microbiota transplantation is recommended. This document provides the international frame to which the book's red flags and hospital-referral signs are aligned.

[033] Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the National Academy of Sciences of the United States of America. 2011. Link

Stanford-based longitudinal study tracking the gut microbiota of three individuals over 10 months across two consecutive courses of ciprofloxacin, with deep 16S rRNA sequencing. Loss of bacterial diversity was profound and rapid, occurring within 3-4 days of antibiotic initiation, and recovery toward the pre-treatment state was often incomplete months after cessation. Repeated antibiotic exposure produced incremental, non-recoverable shifts in community composition. With over 2,000 citations, this paper is the canonical reference establishing that antibiotic-induced dysbiosis is not a self-correcting disturbance but can leave a lasting ecological imprint – central to the case for MTT in patients with cumulative antibiotic exposure history.

[036] Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015. Link

Landmark Nature paper showing that two ubiquitous dietary emulsifiers – carboxymethylcellulose (CMC, E466) and polysorbate-80 (P80, E433) – induced low-grade intestinal inflammation even at relatively low concentrations, altered microbiota composition, and produced obesity/metabolic syndrome in wild-type mice. The authors themselves note that the extent of human emulsifier consumption is not tracked, but that, given how widespread emulsifiers are in food production, actual human exposure may exceed the 1.0 percent level used in the experiment. In mice predisposed to colitis, the same compounds triggered overt colonic inflammation. The authors propose emulsifier exposure as a contributor to the post-1950 rise in IBD and metabolic disease. A corrigendum has been issued for the paper (Corrigendum: *Nature* 2016;536(7615):238). This is the central evidence cited in Section 8.3 of this Guide regarding industrial food production as a chronic input into dysbiosis.

[037] Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017. Link

Follow-up to Chassaing 2015 extending the findings from mice to a human-microbiota model (the M-SHIME ex vivo system). Both emulsifiers increased the pro-inflammatory potential of the microbiota, demonstrably so through elevated flagellin levels; the composition of the community, however, was altered only by P80, while the effect of CMC operated through microbiota gene expression. The rise in lipopolysaccharide levels occurred only with P80, and at higher doses. When a suspension of the emulsifier-treated microbiota was administered to immunodeficient (RAG−/−) mice, serum IL-6 levels rose significantly. The work confirms that the murine findings translate to human gut ecology and reinforces the argument that dietary reform is a clinical, not an aesthetic, component of the maintenance phase.

[077] Atarashi K, Suda W, Luo C et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017. Link

This gnotobiotic study showed that salivary Klebsiella strains, when colonizing the gut, are strong inducers of T helper 1 (TH1) cells. These antibiotic-resistant Klebsiella strains colonize when intestinal microbiota are dysbiotic and elicit severe gut inflammation in genetically susceptible hosts. The findings establish the oral cavity as a reservoir for potential intestinal pathobionts that exacerbate disease such as IBD when ectopically colonizing the gut.

[080] Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. . 2016. Link

In mice on a low microbiota-accessible carbohydrate (fiber) diet, gut microbiota diversity declined and the effect compounded across generations: over four generations the low-fiber diet led to cumulative taxon extinctions no longer reversible by dietary fiber reintroduction.

[097] Palleja A, Mikkelsen KH, Forslund SK et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology. 2018. Link

Shotgun-metagenomic study of 12 healthy men: after a 4-day course of three last-resort antibiotics (meropenem, gentamicin, vancomycin) the gut microbiota largely but incompletely recovered over six months — several common species stayed missing and resistance genes were transiently enriched.

[098] Karmisholt Grosen A et al. Effects of clinical donor characteristics on the success of faecal microbiota transplantation for patients in Denmark with Clostridioides difficile infection: a single-centre, prospective cohort study. The Lancet Microbe. 2025. Link

Single-centre, prospective Danish cohort: clinical donor characteristics — including antibiotic exposure in the 12 months before donation and donation stool consistency — affect FMT success in recurrent C. difficile infection; donor antibiotic use worsens outcomes, supporting strict donor screening.

[161] Dimidi E, Cox SR, Rossi M, Whelan K. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. Nutrients. 2019. Link

Review defining fermented foods as products of controlled microbial growth and enzymatic substrate conversion, characterizing common items (kefir, kombucha, sauerkraut, tempeh, natto, miso, kimchi, sourdough bread) and their proposed mechanisms — including microbiota effects. The review summarizes evidence for fermented-food impact on human gastrointestinal health and disease, supporting selective incorporation into health-promoting dietary patterns.

[238] Chassaing B, Compher C, Bonhomme B et al. Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome. Gastroenterology. 2022. Link

16-subject controlled-feeding RCT in human volunteers. Diet containing carboxymethylcellulose (CMC, E466) emulsifier altered gut microbiota composition within 11 days, decreased microbial diversity and fermentation metabolite levels, and two participants showed signs of bacterial encroachment into the mucus layer. First human evidence that CMC at approved daily exposure levels has detrimental microbiological effects.